Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
Condition(s):Microvascular AnginaLast Updated:May 21, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Microvascular AnginaLast Updated:May 21, 2019Completed
Condition(s):Interstitial Lung Disease; Scleroderma; Idiopathic Pulmonary FibrosisLast Updated:July 30, 2020Unknown status
Condition(s):AgingLast Updated:January 8, 2016Completed
Condition(s):Chronic Obstructive Pulmonary Disease (COPD)Last Updated:April 19, 2011Completed
Condition(s):Adrenergic Beta-2 Agonist Effect; Albuterol EffectLast Updated:October 2, 2017Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:December 17, 2012Completed
Condition(s):Sarcopenia; Frailty; AgingLast Updated:December 17, 2019Terminated
Condition(s):Dyspnea; Malignant NeoplasmLast Updated:December 7, 2022Active, not recruiting
Condition(s):Emphysema; Alveolitis, Fibrosing; Cystic Fibrosis; Bronchiectasis; Lung DiseasesLast Updated:September 7, 2005Unknown status
Condition(s):Friedreich AtaxiaLast Updated:March 18, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.